Sticking With This Ocular Therapeutix Price Target as Key Treatment Moves Forward
The small-cap healthcare firm offered some encouraging earnings results.
Adding to a Couple of Troubled Positions as July Comes to a Close
Here’s our trading plan for Friday and the upcoming earnings calendar for portfolio names.
Cutting SoFi as ‘Misleading’ Report Continues to Weight on Share Price
The financial services firm has taken a turn for the worse.
Selling 5 Small-Cap Names for a LIFO Profit
We looked to take advantage of some pre-earnings weakness and now we’re ready to profit.
5 Stocks We Want to Buy on Weakness Ahead of Earnings
Here’s our shopping list for Friday as well as the latest portfolio news.
Our Small-Cap Defense Name Surges After $70 Million Update
Plus, SoFi is set to release some important earnings data.
Buying More of This Small-Cap Name as Shares Fall Under Pressure
We’re also looking to take some profit after a $6.9 million update boosted another name.
Our Ocular Call Is Set to Expire as Market Struggles
We’re a bit handcuffed when it comes to making moves in our small-cap portfolio.
After a Tough Run for the $10K Portfolio, Time to Get Back in the Win Column
From up 32% to slightly underwater, here’s what recently went awry — and what’s next.
Two Charts, Three Buys and a Fourth Attempt
Planet Labs and Evolv both sit at critical technical areas. Here’s my trading plan.